|
|||
2010-08-11 13:30:00 CEST 2010-08-11 13:30:19 CEST REGULATED INFORMATION Biotie Therapies - Major shareholder announcementsNotification according to Chapter 2, Section 10 of the Finnish Securities Market ActBIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE August 11, 2010 at 2.30 p.m. Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act Biotie Therapies Corp. ("Company") has gained knowledge of the notifications regarding the following changes in holdings in accordance with Chapter 2, Section 9 of the Finnish Securities Markets Act. Pequot Capital Management, Inc (SEC-registration number 801-56015) address 187 Danbury Road, Wilton, CT 06897, United States of America ('Pequot') has notified Company that as a result of share transactions carried out on 26 July, 2010 certain changes in holdings of the Company's shares have taken place between various funds and trusts that are under Pequot's management. As a result of these internal share transactions, the aggregate holdings of Pequot remained unchanged. Though holdings by certain individual funds and trusts changed, none of the holdings of the individual Funds did not reach, exceed or fall below any shareholding disclosure threshold. The changes in holdings in accordance with Chapter 2, Section 9 of the Finnish Securities Markets Act of which the Company has gained knowledge are described below. Name of the Shares prior to the Shares after the % of shares after shareholder transactions transactions the transactions Pequot Healthcare 4,688,170 0 0 Fund, L.P., 187 Danbury Road, Wilton, CT 06897, United States of America; Pequot Healthcare 3,686,577 0 0 Offshore Fund, Inc., Craigmuir Chambers, c/o Harneys Corporate Services Limited, PO Box 71, Road Town, Tortola, British Virgin Islands; Pequot Diversified 751,000 0 0 Master Fund, Ltd., c/o Harneys Corporate Services Limited, Craigmuir Chambers, PO Box 71, Road Town, Tortola, British Virgin Islands; Pequot Healthcare 1,288,406 0 0 Institutional Fund, L.P 187 Danbury Road, Wilton, CT 06897,United States of America; Pequot Healthcare 2,040,770 0 0 Emerging Markets Master Fund, Ltd., Walker House, c/o Walker SPV Limited, Mary Street, PO Box 908GT, George Town, Grand Cayman, Cayman Islands Pequot Diversified 0 751,000 0.47% Liquidating Trust, c/o Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, DE 19890, United States of America Pequot HC 0 4,688,170 2.95% Liquidating Trust, c/o Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, DE 19890, United States of America Pequot HC EM 0 2,040,770 1.29% Liquidating Trust, c/o Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, DE 19890, United States of America Pequot HC 0 1,288,406 0,81% Institutional Liquidating Trust, c/o Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, DE 19890, United States of America Pequot HC Offshore 0 3,686,577 2,32% Liquidating Trust, c/o Wilmington Trust Company, Rodney Square North, 1100 North Market Street, Wilmington, DE 19890, United States of America. Total 12,454,923 12,454,923 7.85 % The registered number of shares in Biotie Therapies Corp. is 158,752,560 and the number of voting rights attached to the shares amounts to 158,752,560. Of these shares 463.255 are owned by the Company. Turku, August 11, 2010 Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Biotie Therapies Corp. tel. +358 2 274 8900 e-mail:virve.nurmi@biotie.com DISTRIBUTION NASDAQ OMX Helsinki Ltd Main Media www.biotie.com [HUG#1437166] |
|||
|